-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O48My1R/LUHHtfyWVagSNzl1RAW6S1iTxp0XSCmPabwle4EHTvEyo1bAZsn6mDba bEj1LVGqGIcH5eW1+kPH0w== 0001181431-06-059202.txt : 20061023 0001181431-06-059202.hdr.sgml : 20061023 20061023152911 ACCESSION NUMBER: 0001181431-06-059202 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20061016 FILED AS OF DATE: 20061023 DATE AS OF CHANGE: 20061023 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jester J Gregory CENTRAL INDEX KEY: 0001378139 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51534 FILM NUMBER: 061157761 BUSINESS ADDRESS: BUSINESS PHONE: 212-716-1810 MAIL ADDRESS: STREET 1: C/O INNOVIVE PHARMACEUTICALS, INC. STREET 2: 555 MADISON AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innovive Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001337223 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 743123261 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 555 MADISON AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-716-1810 MAIL ADDRESS: STREET 1: 555 MADISON AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 3 1 rrd133211.xml INITIAL FORM 3 X0202 3 2006-10-16 0 0001337223 Innovive Pharmaceuticals, Inc. IVPH.OB 0001378139 Jester J Gregory 555 MADISON AVENUE 25TH FLOOR NEW YORK NY 10022 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 3.96 2017-10-16 Common Stock 90000 D Option vests in three equal annual installments beginning on October 16, 2007. /s/ W. David Mannheim, Attorney-in-Fact 2006-10-23 EX-24. 2 rrd116880_131428.htm rrd116880_131428.html

        POWER OF ATTORNEY


        Know all by these presents that the undersigned hereby constitutes and appoints each of Steven Kelly, Eric Poma and W. David Mannheim, and each of them acting alone, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or 10% or more stockholder of Innovive Pharmaceuticals, Inc. (the "Company"), Forms ID, 3, 4 and 5 and Schedules 13D or 13G (and any amendments thereto) under Section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended (the "1934 Act") in accordance with the 1934 Act, and the rules promulgated thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form or Schedule (and any amendments thereto) and to file timely such Form or Schedule wi th the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which in the opinion of such attorney-in-fact may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitut ion or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 13(d) or 16(a) of the 1934 Act.

        This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file such Forms or Schedules with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has ca used this Power of Attorney to be executed as of this 11th day of October 2006.


                                                /s/ J. Gregory Jester
                                                J. Gregory Jester


-----END PRIVACY-ENHANCED MESSAGE-----